Physician profile
Whitney Workman
NPI 1790220747
$2,654.59
in general payments reported to CMS, 2019-2025
17 companies · $23.23 in 2025
The $23.23 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,451 · 2022: $597 · 2023: $452 · 2024: $131 · 2025: $23.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.65 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,452.23 | 2021-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $317.79 | 2021-2023 | Myrbetriq |
| Urovant Sciences INC | $295.79 | 2021-2022 | |
| Coloplast Corp | $76.04 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $75.53 | 2023-2024 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $69.31 | 2022-2024 | Xiaflex |
| Boston Scientific Corporation | $66.62 | 2022-2023 | Rezum Generator |
| Antares Pharma, INC. | $64.41 | 2021-2024 | Xyosted |
| Tolmar, INC. | $53.22 | 2023-2025 | Eligard, Jatenzo |
| Progenics Pharmaceuticals, INC. | $43.06 | 2023 | Pylarify |
| Blue Earth Diagnostics | $33.63 | 2022 | |
| Procept Biorobotics Corporation | $26.41 | 2023 | Aquabeam Robotic System |
| Pfizer INC. | $18.62 | 2022 | |
| Halozyme INC | $18.20 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $15.20 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.33 | 2023 | Interstim |
| Endo USA, INC. | $14.20 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.